Shanghai Jiaotong University School of Medicine affiliated Renji Hospital has launched the first blockchain-enabled intelligent tumour treatment centre in partnership with VeChain and DNV GL.
The intelligent tumour treatment centre combines VeChain blockchain technology with DNV GL’s professional services. It enables full patient ownership of personal medical records, allowing patients to take control of the authorisation and medical records data management. Research institutions inside and outside the hospital can use authorised data to improve the efficiency of clinical research, while regulatory agencies can use authorised data to conduct business compliance checks on medical institutions and establish a credit evaluation system.
“Moving forward, Renji intends to boost our healthcare facilities with more blockchain-powered use cases and projects, which will be gradually disclosed together with our partners when the time is right,” said Zhang Jidong, vice president of Renji Hospital.
In line with the Chinese Government’s 14th Five-Year (2021-2025) Plan for Economic and Social Development, the National Health Commission formulated an official guideline and re-emphasised blockchain technology as an essential innovation and integration of the medical and health industry
Launched in 2015, VeChain connects blockchain technology to the real world by providing a comprehensive governance structure, a robust economic model, and IoT integration. It is the pioneer of real-world applications using public blockchain technology, with international operations in Singapore, Luxembourg, Tokyo, Shanghai, Paris, Hong Kong, and San Francisco.
Copyright @ 2020 Laingbuissonnews
Published here at Laingbuissonnews
